Document is current
Any future updates will be listed below
-
Authors
Maakaron, Joseph E. https://orcid.org/0000-0002-1732-6694
Zhang, Mei-Jie
Chen, Karen
Abhyankar, Sunil https://orcid.org/0000-0002-8578-1226
Bhatt, Vijaya Raj https://orcid.org/0000-0003-2513-0533
Chhabra, Saurabh https://orcid.org/0000-0001-9117-8696
El Jurdi, Najla https://orcid.org/0000-0002-9268-9655
Farag, Sherif S. https://orcid.org/0000-0002-3088-843X
He, Fiona https://orcid.org/0000-0003-0782-1170
Juckett, Mark
de Lima, Marcos https://orcid.org/0000-0002-8568-4522
Majhail, Navneet
van der Poel, Marjolein
Saad, Ayman https://orcid.org/0000-0003-0003-0130
Savani, Bipin
Ustun, Celalettin https://orcid.org/0000-0001-6896-6213
Waller, Edmund K.
Litzow, Mark https://orcid.org/0000-0002-9816-6302
Kebriaei, Partow https://orcid.org/0000-0002-8607-9404
Hourigan, Christopher S.
Saber, Wael
Weisdorf, Daniel https://orcid.org/0000-0001-8078-8579
- License Information
-
More Information
Article History
Received: 20 October 2021
Revised: 8 March 2022
Accepted: 16 March 2022
First Online: 2 April 2022
Competing interests
: Daniel Weisdorf reports grants from FATE Therapeutics, grants from Incyte, outside the submitted work. Christopher S Hourigan reports other from Sellas, outside the submitted work. Joseph E Maakaron reports other from CRISPR, other from FortySeven Inc., other from TALARIS, outside the submitted work. Marcos de Lima reports grants from Pfizer grants from Celgene, personal fees from Kadmon personal fees from Pfizer, personal fees from Incyte, personal fees from BMS, outside the submitted work. Vijaya Raj Bhatt reports personal fees from Agios, grants and personal fees from Incyte, personal fees from Takeda, personal fees from Partner Therapeutics, personal fees from Omeros, grants and personal fees from Abbvie, grants from Jazz, grants from National Marrow Donor Program, other from Oncoceutics, personal fees from Partnership for health analytic research, LLC, grants and other from Pfizer, personal fees from CSL Behring, grants from Tolero Pharmaceuticals, personal fees from Rigel Pharmaceuticals, other from Novartis, personal fees from Genentech, outside the submitted work. Ayman Saad reports personal fees from Magenta Therapeutics, personal fees from Incyte Pharmaceuticals, personal fees from CareDx, outside the submitted work. Partow Kebriaei reports grants from Amgen, grants from Ziopharm, other from Kite, other from Novartis, other from Jazz, other from Pfizer, outside the submitted work. Celalettin Ustun reports not relevant, but honoria from Novartis and Blueprint for attending advisory board meeting. Fiona He reports personal fees from Magenta Therapeutics, outside the submitted work. Sunil Abhyankar reports other from Incyte Corporation, other from Therkos, outside the submitted work. Navneet Majhail reports personal fees from lncyte, personal fees from Anthem, Inc., personal fees from Nkarta, personal fees from Mallinckrodt, outside the submitted work.
